Qingsong Wu

Dr. Qingsong Wu


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2008 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
LTLi Tuo
Li Tuo
THTao He
Tao He
XTXiaodong Tan
Xiaodong Tan
SYShurong Yang
Shurong Yang
JLJiazhang Li
Jiazhang Li
YXYiqiao Xing
Yiqiao Xing

5 July 2025 in Communications Biology
Verified
Journal Article
Open access
PDF file
ZZZhaofeng Zhang
Zhaofeng Zhang
LXLinfeng Xie
Linfeng Xie
XLXinfan Lin
Xinfan Lin
JHJian He
Jian He
YXYuling Xie
Yuling Xie
LCLiangwan Chen
Liangwan Chen
Aortic aneurysm and dissection (AAD) are severe cardiovascular conditions that carry significant risks and currently lack an effective treatment. Ursodeoxycholic acid (UDCA) can delay the onset of various metabolic diseases such as type 2 diabetes and obesity. However, it remains unclear whether UDCA can delay the onset of AAD. We demonstrated pathological activation of the intestinal Farnesoid X receptor (FXR) in both AAD patients and AAD mice. UDCA significantly suppressed intestinal FXR activation. In vivo experiments demonstrated that knockdown of intestinal FXR in mice using adeno-associated virus (AAV) reduced the incidence of AAD, reduced macrophage infiltration, and improved extracellular matrix degradation. In vitro experiments demonstrated that activating intestinal FXR increases the expression of ceramide synthase 2 (Cers2), which participates in the de novo synthesis of ceramides, and promotes the release of C20 ceramide. C20 ceramide promotes extracellular matrix metalloproteinases (MMPs) release from macrophages, leading to extracellular matrix degradation and contributing to AAD development. Our findings highlight the role of UDCA in reducing AAD incidence, revealing the therapeutic potential of the intestinal FXR/Cers2 axis against AAD.

22 August 2022 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
PDF file
QWQingsong Wu
Qingsong Wu
DJDebin Jiang
Debin Jiang
XLXiaochai Lv
Xiaochai Lv
JZJiaxin Zhang
Jiaxin Zhang
RHRongda Huang
Rongda Huang
LCLiangwan Chen
Liangwan Chen
Objective. To compare the efficacy of the percutaneous presuture technique (PPST) and the femoral artery incision technique (FAIT) under local anesthesia in the treatment of endovascular aortic repair (EVAR) for patients with uncomplicated type B aortic dissection (uTBAD). Method. Two hundred and ninety-five patients diagnosed with uTBAD who underwent EVAR under local anesthesia from June 2017 to December 2021 were consecutively and randomly selected for retrospective analysis. The PPST was performed in 178 cases and the FAIT was performed in 117 cases. The clinical characteristics and surgical and postoperative data from the two groups were analyzed. Results. There were no significant differences in clinical characteristics between the two groups ( ). The operative time of the PPST group was significantly shorter than that of the FAIT group (46 (33, 58) versus 72 (67.5, 78.0) minutes, ), as was the operative approach procedure time (6 (4.5, 9.0) versus 38 (36.5, 43.5) minutes, ), and length of postoperative hospital stay (5.19 ± 2.26 versus 8.33 ± 3.76 days, ). There were fewer postoperative approach-related procedural complications in the PPST group than in the FAIT group (2 versus 12, ); similarly, the average frequency of postoperative wound disinfection was significantly lower in the PPST group (1.08 ± 0.39 versus 3.31 ± 0.91 times, ). Obesity was identified as an independent risk factor for postoperative approach-related procedural complications (OR, 22.26; 95% CI, 4.74–104.49; ). Conclusions. The PPST has comparable safety and efficacy to the FAIT in EVAR under local anesthesia. It can shorten the length of hospital stay, reduce operation time, lower the risk of wound-related complications, reduce the frequency of postoperative wound disinfection, and hasten postoperative recovery. It can therefore be used as a first-line surgical technique in EVAR of uTBAD under local anesthesia, especially in obese patients.

4 February 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
XZXinghui Zhuang
Xinghui Zhuang
MZMohammad Zarif
Mohammad Zarif
YSYue Shen
Yue Shen
ZZZhaofeng Zhang
Zhaofeng Zhang
JHJian He
Jian He
LCLiangwan Chen
Liangwan Chen
Background: Apolipoprotein C3 (apo C3) is primarily secreted by the liver and is involved in promoting sterile inflammation and organ damage under pathological conditions. Previous studies have shown that apo C3 is abundant in the plasma exosomes of patients with aortic dissection (AD), but its specific role in AD remains unclear. Methods and Results: In vivo, adeno‐associated virus was used to knock down hepatic apo C3 expression in an AD mouse model to assess the impact of liver‐derived apo C3 on the development of AD. In vitro, recombinant apo C3 protein was added to the culture medium of J774A.1 macrophages to evaluate its effect on macrophage polarization and to identify the underlying mechanisms. Additionally, the effect of apo C3 on the function of aortic endothelial and smooth muscle cells was explored. Apo C3 in the aortas of AD mice was found to originate from abnormal hepatic secretion, which enters the bloodstream and subsequently deposits in the aorta. Adeno‐associated virus–mediated hepatic apo C3 knockdown significantly reduced AD incidence ( P =0.0036), macrophage infiltration ( P =0.0004), and collagen deposition in the aorta ( P =0.0016). Similarly, inhibiting the apo C3 receptor Toll‐like receptor 2 significantly lowered AD incidence ( P =0.0352). In vitro, recombinant apo C3 protein promoted M1 polarization and matrix metalloproteinase secretion in macrophages by activating the Toll‐like receptor 2/NLR family pyrin domain containing 3 pathway. Additionally, apo C3 increased adhesion molecule expression in endothelial cells and induced inflammation, chemotaxis, and apoptosis in vascular smooth muscle cells. Conclusions: Our findings highlight the role of abnormally secreted hepatic apo C3 in promoting aortic inflammation.

2 September 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
XLXin‐Fan Lin
Xin‐Fan Lin
HGHang‐Qi Gao
Hang‐Qi Gao
QWQingsong Wu
Qingsong Wu
YXYu‐Ling Xie
Yu‐Ling Xie
LCLiangwan Chen
Liangwan Chen
LXLinfeng Xie
Linfeng Xie
Background: This study aimed to validate the predictive performance of the GERAADA (German Registry for Acute Type A Aortic Dissection) score in predicting 30‐day mortality rate in patients with acute type A aortic dissection in China. Methods: We retrospectively analyzed 526 patients who underwent surgical treatment for acute type A aortic dissection at our institution between 2018 and 2021. The predictive performance of the GERAADA score was evaluated using calibration (observed‐to‐expected ratio and Hosmer–Lemeshow test) and discrimination (area under the receiver operating characteristic curve). Logistic regression analysis was performed to identify risk factors of 30‐day mortality rate. Stratified analyses were conducted to assess performance across different risk categories. Results: The cohort exhibited distinct characteristics, including younger age, longer intervals from onset to admission, and more extensive aortic arch procedures. The GERAADA score demonstrated good calibration (Hosmer–Lemeshow test, P =0.461) and discriminative power (area under the receiver operating characteristic curve=0.863). Low‐risk patients (score <20; 78.7% of cohort) had a mortality rate of 2.4%, while high‐risk patients (score ≥20) showed mortality rates aligning with predicted values (observed‐to‐expected ratio=1.2). Patients with preoperative critical conditions or end‐organ malperfusion exhibited a significantly higher mortality rate. Furthermore, we identified independent risk factors beyond the GERAADA scoring system, and these factors exhibited significant differences between high‐ and low‐risk patients. To address these findings, we developed a mortality risk assessment strategy based on GERAADA score, which further stratifies patients according to their specific clinical characteristics, serving as an optimization and expansion of the GERAADA score. Conclusions: This study validated the GERAADA score in China for predicting mortality risk in patients with acute type A aortic dissection, showing strong performance in discrimination and calibration. We also developed a mortality risk assessment strategy based on the GERAADA score, offering a practical framework for clinical use. The modular design allows for easy adaptation across centers, although further multicenter studies are needed to confirm its generalizability.

29 November 2022 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
QWQingsong Wu
Qingsong Wu
YSYue Shen
Yue Shen
LXLinfeng Xie
Linfeng Xie
JZJiaxin Zhang
Jiaxin Zhang
ZQZhihuang Qiu
Zhihuang Qiu
LCLiangwan Chen
Liangwan Chen